Nephros (NEPH) vs Retractable Technologies (RVP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Retractable Technologies (RVP) has outperformed Nephros (NEPH) over the past year, losing 28.0% versus a loss of 36.2%. Over five years, NEPH leads with a -57.6% price change compared with -92.8% for RVP. Nephros is the larger company by market cap ($37.6 million vs $19.9 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NEPH | RVP |
|---|---|---|
| Share price | $3.47 | $0.6632 |
| Market cap | $37.63M | $19.85M |
| 1-day change | +5.32% | +0.18% |
| YTD return | -32.58% | -14.03% |
| 1-year return | -36.24% | -28.04% |
| 5-year return | -57.60% | -92.76% |
| P/E ratio (TTM) | 23.10 | — |
| Forward P/E | 16.50 | — |
| EPS (TTM) | $0.15 | $-0.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.42 | $1.14 |
| 52-week low | $2.66 | $0.60 |
| Distance from 52-week high | -46.03% | -41.82% |
| Analyst consensus | none | — |
| Avg. price target upside | +80.38% | — |
| Average volume | 27.59K | 27.81K |
| Shares outstanding | 10.86M | 29.94M |
| Employees | 36 | 195 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Nephros
NEPH stock →Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities.
Health Care · Medical/Dental Instruments · 36 employees
About Retractable Technologies
RVP stock →Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
Health Care · Medical/Dental Instruments · 195 employees
NEPH vs RVP FAQ
Which is bigger, Nephros or Retractable Technologies?
Nephros (NEPH) is larger, with a market capitalization of $37.63M compared with $19.85M for Retractable Technologies (RVP).
Which stock has performed better over the past year, NEPH or RVP?
RVP returned -28.04% over the past 12 months, compared with -36.24% for NEPH (price return, excluding dividends). Past performance does not predict future results.
Are Nephros and Retractable Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.